Tools

Support

Start Your Investment Journey With UsOPEN ACCOUNT

Piramal Pharma Ltd. Share Price

179.85 -1.00 (-0.55%)

Piramal Pharma is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. We operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (“CDMO”) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (“APIs”), Finished dosage forms (“FDFs”), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (“CHG“) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and Piramal Consumer Healthcare (“PCH“) business, selling well-known OTC brands.

Fundamentals

Market Cap

₹24,040Cr

EPS

₹0.68

Book Value/Share

₹59.53

Industry P/E (TTM)

41.20

P/B Ratio

2.94

Long Term D/E

0.59

ROE

1.13%

Dividend Yield (TTM)

0.10%

Factor Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Underperformer

Very Expensive

Average Quality

Low Price Fluctuation

Analysts are Very Bearish

Peer Comparison

Peer comparison lists companies from the same sector, scored and ranked based on Factor Analysis. It helps understand how a company stands against its competitors.

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Piramal Pharma Ltd.

Piramal Pharma Ltd. share price is ₹179.85 as of 05/12/2025, 6:51:38 pm. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

Piramal Pharma Ltd. reported an ROE of 1.13 for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Piramal Pharma Ltd., Promoter held 34.90%, the FII held 30.30%, DII held 14.90%, and the public held 19.50% of the total shares.

You can easily buy shares of Piramal Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Piramal Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

No data

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

No data

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

No data

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages0

Bearish Moving Averages16

5 Day

184.00

10 Day

185.40

20 Day

189.60

30 Day

193.70

50 Day

194.30

100 Day

196.40

150 Day

199.10

200 Day

202.30

Indicators

RSI (14)

30.11

MACD (12, 26)

-3.78

MACD Signal Line (9)

-3.05

MFI (14)

26.75

ATR (14)

4.42

ADX (14)

15.33

ROC (21)

-9.76

ROC (125)

-13.09

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

No data

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.